::: Protalix BioTherapeutics Names Tzvi Palash Chief Operating Officer
Protalix BioTherapeutics, biopharmaceutical company, biotechnology company, Production Manager, Tzvi Palash, product development, Plant Manager, General Manager

::: Precision BioSciences Wins Stay of Patent Litigation Brought by Cellectis
Precision BioSciences, CSO of Precision, CEO of Precision, patent infringement litigation, Patent Litigation, reexamination proceedings, industry-leading DNE technology, Patent Nos, patent holders, endonuclease technology

::: First AXL1717 clinical data from ongoing Phase I/II study in cancer patients has been published
First AXL1717 clinical data, months of AXL1717 treatment, IGF-1 receptor inhibitor drugs, CEO Axelar AB, cancer patients, oral small-molecule IGF-1 receptor inhibitor, IGF-1 receptor signal pathway, pharmacokinetics of AXL1717, insulin receptor, density of the IGF-1 receptor

::: Stallergenes and Shionogi sign exclusive partnership agreements for immunotherapy tablets in Japan
Japanese cedar allergy, Japanese cedar pollen tablets, house dust mite allergy, Japanese allergy market, respiratory allergy sufferers, immunotherapy tablets, allergy treatments, house dust mite tablets, strong allergy franchise

::: Myconostica Announces CE Marking of MycAssay™ Aspergillus For Serum
diagnosis of Aspergillus infections, detection of Aspergillus DNA, detection of Aspergillus spp DNA, Aspergillus aid physicians, CE Marking of MycAssay, life-threatening fungal infections, existing CE marking, detection of fungal infections, serum samples, CE marked